The present stock price for Takeda Pharmaceutical Co ADR (TAK) is $14.72. In the last trading session, the stock made a considerable jump, reaching $18.51 after an opening price of $14.72. The stock briefly fell to $15.19 before ending the session at $14.75.
Takeda Pharmaceutical Co ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $15.53 on 07/01/25, while the lowest price for the same duration was marked at $12.80 on 01/23/25.
52-week price history of TAK Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Takeda Pharmaceutical Co ADR’s current trading price is -5.22% away from its 52-week high, while its distance from the 52-week low is 15.00%. The stock’s price range during this period has spanned from $12.80 to $15.53. In the Healthcare sector, the Takeda Pharmaceutical Co ADR’s shares surpassed a trading volume of approximately 3.6 million for the day, which was noticeably higher compared to the average daily volume of 9.2.17 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Takeda Pharmaceutical Co ADR (TAK) has experienced a quarterly rise of 2.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 46.33B and boasts a workforce of 47455 employees.
A Closer Look at Analysts’ Ratings for Takeda Pharmaceutical Co ADR
As of right now, 3 analysts are rating Takeda Pharmaceutical Co ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.83, with a change in price of +0.86. Similarly, Takeda Pharmaceutical Co ADR recorded 2,137,951 in trading volume during the last 100 days, posting a change of +6.20%.
Examining TAK’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TAK stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.65.
TAK Stock Stochastic Average
Today, Takeda Pharmaceutical Co ADR’s raw stochastic average for the past 50 days stands at 59.09%, indicating a rise from the raw stochastic average of the last 20 days, which was 16.09%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 28.17% and 28.29% respectively.
TAK Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 9.52% this year. Over the last six months, there has been a weaker performance of 13.32%. The price of TAK leaped by -3.16% during the last 30 days period. For the last 5-days stocks have slided -2.71%.
